Prosecution Insights
Last updated: October 02, 2026

Examiner: WITTLIFF, KATERINA ANNA

Tech Center 3700 • Art Units: 2841 3746 3783 3792

This examiner grants 35% of resolved cases

Analysis

Katerina Anna Wittliff is a patent examiner in Tech Center 3700 and Art Unit 2841. The examiner has 20 resolved cases. The allowance rate for these cases is 35.0 percent. This percentage represents the proportion of applications that reach a grant. The 20 resolved cases provide a factual basis for understanding the examiner's history in this art unit.

The interview lift is 18.8 percent. This figure indicates the difference in allowance probability for cases that include an interview. The median days to allowance is 1401. This number shows the time from filing to grant for successful applications. Practitioners can use the 35.0 percent allowance rate and the 1401 median days to allowance to set expectations for the prosecution process. These data points offer a grounded view of the examiner's actions. The interview lift of 18.8 percent is a statistical measure of the impact of direct communication during the examination of patent applications.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

35.0%
Allow Rate
-35.0% vs TC avg
69
Total Applications
+18.8%
Interview Lift
1401
Avg Prosecution Days
Based on 20 resolved cases, 2023–2026

Rejection Statute Breakdown

1.5%
§101 Eligibility
20.4%
§102 Novelty
59.0%
§103 Obviousness
16.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17949734 Introducer Adapters, Introducer Assemblies, and Methods Non-Final OA Bard Access Systems, Inc.
18037113 BREAST SHIELD FOR A BREAST PUMP Final Rejection KONINKLIJKE PHILIPS N.V.
18231997 Clip on Torque Device for Endovascular Procedures Final Rejection Wisconsin Alumni Research Foundation
17630219 CATHETER HAVING CONNECTOR WITH ELECTRICAL CONDUCTOR CONNECTIONS Non-Final OA BIOTRONIK AG
18740828 METHODS AND APPARATUS FOR SUBRETINAL DELIVERY Non-Final OA Alcon Inc.
18207618 SAFE OPERATION OF INTEGRATED NEGATIVE PRESSURE WOUND TREATMENT APPARATUSES Non-Final OA Smith & Nephew PLC
17980090 SYRINGE WITH BIASING MEMBER Non-Final OA CareFusion 303, Inc.
17573582 SYSTEM AND METHOD FOR REDUCED INFUSION ADMINISTRATION LINE ERROR Final Rejection CareFusion 303, Inc.
18853083 METHOD AND SYSTEM FOR MONITORING A WASTE STREAM TO INCREASE EFFICIENCY OF A SURGICAL IRRIGATION PROCEDURE Non-Final OA CareFusion 2200, Inc.
18071765 VASCULAR ACCESS SYSTEM Final Rejection ABIOMED, Inc.
17963813 Low-Profile Single and Dual Vascular Access Device Non-Final OA C. R. Bard, Inc.
17852574 Protective Cover for a Medical Device Non-Final OA Becton, Dickinson and Company
17852526 Non-Integrated Catheter System Having an Extension Set Final Rejection Becton, Dickinson and Company
17851641 Instrument Advancement Device Configured for Septum Engagement Non-Final OA Becton, Dickinson and Company
18242110 MEDICAL BALLOON ASSEMBLY, USE THEREOF, AND METHOD OF DEPLOYING A MEDICAL BALLOON ASSEMBLY Non-Final OA Cook Medical Technologies LLC
17961206 ALERTS IN AMBULATORY INFUSION PUMP SYSTEMS Non-Final OA Tandem Diabetes Care, Inc.
18057258 CATHETER Final Rejection TERUMO KABUSHIKI KAISHA
17383974 MEDICAL CONNECTORS AND METHODS OF USE Non-Final OA ICU Medical, Inc.
17852480 METALLIC SUPPORT STRUCTURE IN THE DRIVE ARM/HEAD OF A MEDICAL FLUID PUMP Final Rejection B. Braun Melsungen AG
17828794 Compositions And Methods For Treating With A Combination Of Alternating Electric Fields And Trastuzumab Final Rejection NOVOCURE GMBH
17770349 DRUG DELIVERY SYSTEM AND METHOD OF USE Final Rejection AMGEN INC.
17770341 DRUG DELIVERY DEVICE AND SYSTEM Non-Final OA AMGEN INC.
17767469 DRUG DELIVERY DEVICE AND SYSTEM Final Rejection AMGEN INC.
17924119 UNIDIRECTIONAL-DRIVEN DRUG INFUSION DEVICE Non-Final OA MEDTRUM TECHNOLOGIES INC.
18290565 COUPLING DEVICE FOR A MEDICAL PUMP Non-Final OA NOVANTA MEDICAL GMBH

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month